Article
Recent FDA Guidance Addressing Platform Technologies
On May 29, 2024, the U.S. Food and Drug Administration ("FDA") released draft guidance titled Platform Technology Designation Program for Drug Development.

WilmerHale
Use advanced search filters to refine your search

